The Science Based Targets initiative (SBTi) has approved SHL Medical’s near-term science-based emissions reduction target, underlining the company’s dedication to remaining transparent and accountable throughout its entire sustainability journey.
Menu
SHL Medical has joined the NSTC Science Train Program for the second consecutive year as part of its human-centered sustainability approach.
SHL and Lifecore will exchange knowledge and experience in their respective fields, enabling both companies to provide their customers unparalleled guidance in CDMO services and best-in-class options for drug delivery device development.
In the Pre-filled Syringes and Injection Devices Issue of ONdrug Delivery Magazine, published ahead of the 2023 PDA Universe of Pre-filled Syringes and Injection Devices Conference, SHL Medical’s Edwin Hendrawan, Yi-Chi Lu, and Christian Walter detail how simulation technologies have been crucial in continuously strengthening the company’s global manufacturing operations and expansion plans.
SHL Medical announced the launch of a new webpage for its Molly® Connected Cap autoinjector.
The Alliance Management program will further strengthen SHL Medical’s vertically integrated business model by facilitating customer engagement with other key players within the drug delivery ecosystem.
SHL Medical AG reinforces its commitment to sustainability and responsible corporate governance by officially joining the United Nations Global Compact (UNGC).
SHL Medical to speak at PDA Aseptic 2023 on November 1
SHL Medical to exhibit at Booth #2F31 of the 2023 CPHI Barcelona this fall
